NCI 10H03 (Protocol 8611): A Single-Arm Phase II Clinical Trial with the Novel MEK Inhibitor AZD-6244 hydrogen sulfate for the Treatment of MCT-1 Related Relapsed or Refractory Diffuse Large B-cell Lymphoma: Subproject for Institution # SP0012448
- Kuzel, Timothy Michael (PD/PI)
- Gordon, Leo I (Co-Investigator)
Project: Research project